Scarica l'app Stockscreener
62.12
3.93%
2.35
Pre-mercato:
62.41
0.29
+0.47%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$59.77
Aprire:
$59.83
Volume 24 ore:
814.78K
Relative Volume:
0.61
Capitalizzazione di mercato:
$4.12B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
10.34
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
+5.74%
1M Prestazione:
+7.64%
6M Prestazione:
-21.99%
1 anno Prestazione:
-30.08%
Intervallo 1D:
$59.14
$62.60
Intervallo di 1 settimana:
$57.44
$62.60
Portata 52W:
$47.25
$111.29
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Confronta LNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
62.12 | 3.96B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
120.41 | 54.02B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.28 | 45.21B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.53 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.41 | 31.93B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
485.21 | 20.71B | 3.08B | 1.24B | 1.07B | 25.61 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-08 | Downgrade | Goldman | Buy → Neutral |
| 2025-08-12 | Downgrade | Truist | Buy → Hold |
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Is Lantheus Holdings Inc. (0L8) stock a defensive play amid uncertaintyRate Cut & Fast Entry High Yield Tips - Newser
What analysts say about Lantheus Holdings Inc 0L8 stockMean Reversion Trades & Exceptional Capital Trading - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lantheus Holdings, Inc. (LNTH) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
LNTH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (PR Newswire) - Aktiellt
LNTH Shareholders Have Opportunity to Lead Lantheus Holdings, Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lantheus Holdings, Inc. (LNTH) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Levi & Korsinsky Invites Investors to SueWallSt After Lantheus Holdings, Inc. Stock Collapse - The National Law Review
How (LNTH) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Lantheus Holdings (LNTH) To Unveil Florbetaben Data at CTAD 2025 Could Diagnostic Innovation Strengthen Its Edge? - simplywall.st
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lantheus Holdings, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action LawsuitLNTH (PR Newswire) - Aktiellt
What valuation multiples suggest for Lantheus Holdings Inc. stock2025 Biggest Moves & Weekly Return Optimization Plans - BỘ NỘI VỤ
Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lantheus Holdings (LNTH): Taking Stock of Valuation Following CTAD 2025 Clinical Data Announcement - sahmcapital.com
Lantheus Holdings, Inc. (LNTH) Stock Forecasts - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Investors to Connect - ACCESS Newswire
Jefferies Sticks to Their Buy Rating for Lantheus (LNTH) - The Globe and Mail
Lantheus Holdings (LNTH): Assessing Valuation Following Recent Share Price Uptick - Yahoo Finance
Lantheus to Present Florbetaben F 18 Data at CTAD 2025 - The Manila Times
Lantheus (NASDAQ: LNTH) unveils florbetaben data on lecanemab, donanemab at CTAD 2025 - Stock Titan
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Barchart.com
Investors SueWallSt as Lantheus Holdings, Inc. Faces Securities Fraud Allegations - The National Law Review
How risky is Lantheus Holdings Inc. (0L8) stock compared to peersTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Reach Out - ACCESS Newswire
Is Lantheus Holdings Inc. stock oversold or undervaluedShare Buyback & AI Powered Market Entry Strategies - newser.com
Is Lantheus Holdings Inc. (0L8) stock a top hedge fund pickMarket Risk Report & Real-Time Volume Analysis - newser.com
Is Lantheus Holdings Inc. (0L8) stock worth holding before Fed meeting2025 Price Targets & Weekly High Momentum Picks - newser.com
Lantheus Holdings, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:LNTH) 2025-11-20 - Seeking Alpha
Will Lantheus Holdings Inc. stock benefit from automationWeekly Investment Recap & Verified Stock Trade Ideas - newser.com
How Lantheus Holdings Inc. stock valuations compare to rivals2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com
Is Lantheus Holdings Inc. stock attractive for ETFsJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com
Why Lantheus Holdings Inc. stock is favored by pension fundsExit Point & AI Driven Stock Movement Reports - newser.com
Why retail traders accumulate Lantheus Holdings Inc. (0L8) stockWeekly Gains Report & Weekly Setup with High ROI Potential - newser.com
Live market analysis of Lantheus Holdings Inc.Market Movement Recap & Free Weekly Watchlist of Top Performers - newser.com
Can machine learning forecast Lantheus Holdings Inc. recoveryPortfolio Return Report & High Accuracy Swing Entry Alerts - newser.com
Lantheus Holdings Inc. (LNTH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lantheus Holdings, Inc. (LNTH) And Encourages Stockholders to Connect - ACCESS Newswire
Trading Systems Reacting to (LNTH) Volatility - news.stocktradersdaily.com
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
7.96%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):